| Schedule of Reconciliation of the Numerators and Denominators of the Basic and Diluted Earnings Per Share |
The
following represents a reconciliation of the numerators and denominators of the basic and diluted earnings per share computation for
the three and nine months ended September 30, 2025 and 2024:
| | |
Three Months
Ended | | |
Nine Months
Ended | |
| | |
September
30, | | |
September
30, | |
| | |
2025 | | |
2024 | | |
2025 | | |
2024 | |
| Numerator: | |
| | |
| | |
| | |
| |
| Income (loss) from continuing operations | |
$31,252 | | |
$(749,129) | | |
$(1,159,135) | | |
$(2,649,983) | |
| Loss
from discontinued operation, net of tax | |
| - | | |
| (136,813 | ) | |
| - | | |
| (211,030 | ) |
| Net income | |
$ | 31,252 | | |
$ | (885,942 | ) | |
$ | (1,159,135 | ) | |
$ | (2,861,013 | ) |
| Net loss - diluted | |
$ | 31,252 | | |
$ | (885,942 | ) | |
$ | (1,159,135 | ) | |
$ | (2,861,013 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Denominator: | |
| | | |
| | | |
| | | |
| | |
| Weighted average common shares outstanding | |
| 1,619,611 | | |
| 1,593,646 | | |
| 1,615,739 | | |
| 1,579,405 | |
| Effect of dilutive shares | |
| | | |
| | | |
| | | |
| | |
| Preferred
stock | |
| 7,000,000 | | |
| - | | |
| - | | |
| - | |
| Diluted | |
| 8,619,611 | | |
| 1,593,646 | | |
| 1,615,739 | | |
| 1,579,405 | |
| | |
| | | |
| | | |
| | | |
| | |
| Net income (loss) per common share: | |
| | | |
| | | |
| | | |
| | |
| Basic: | |
| | | |
| | | |
| | | |
| | |
| Income
(loss) from continuing operations | |
$ | 0.02 | | |
$ | (0.47 | ) | |
$ | (0.01 | ) | |
$ | (1.68 | ) |
| Loss
from discontinued operations | |
$ | 0.00 | | |
$ | (0.09 | ) | |
$ | 0.00 | | |
$ | (0.13 | ) |
| Net
income (loss) | |
$ | 0.02 | | |
$ | (0.56 | ) | |
$ | (0.01 | ) | |
$ | (1.81 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Diluted | |
| | | |
| | | |
| | | |
| | |
| Income
(loss) from continuing operations | |
$ | 0.00 | | |
$ | (0.47 | ) | |
$ | (0.72 | ) | |
$ | (1.68 | ) |
| Loss
from discontinued operations | |
$ | 0.00 | | |
$ | (0.09 | ) | |
$ | 0.00 | | |
$ | (0.13 | ) |
| Net
income (loss) | |
$ | 0.00 | | |
$ | (0.56 | ) | |
$ | (0.72 | ) | |
$ | (1.81 | ) |
|
|
| Schedule of Common Stock Equivalents, Which are Potentially Dilutive Equity Securities |
At
September 30, 2025 and 2024, respectively, the Company had the following common stock equivalents, which are potentially dilutive equity
securities:
| | |
September
30, | | |
September
30, | |
| | |
2025 | | |
2024 | |
| | |
| | |
| |
| Convertible Preferred Stock | |
| 7,000,000 | | |
| 2 | |
| Convertible notes | |
| 251,137 | | |
| 48,400 | |
| Common stock issuable | |
| - | | |
| 1,000 | |
| Warrant | |
| 51,460 | | |
| 5,145,943 | |
|
At
December 31, 2024 and 2023, respectively, the Company had the following common stock equivalents, which are potentially dilutive equity
securities:
| |
|
December 31,
2024 |
|
|
December 31,
2023 |
|
| |
|
|
|
|
|
|
|
|
| Convertible Preferred Stock |
|
|
700,000,000 |
|
|
|
700,000,000 |
|
|